New balloon treatment for heart disease under Real-World study

NCT ID NCT02038660

Recruiting now Disease control Sponsor: Seung-Jung Park Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is tracking 1,500 people with coronary artery disease who are treated with a drug-eluting balloon during angioplasty. The balloon releases a medicine (paclitaxel) to help keep the artery open. Researchers are checking how well it works and if it is safe over the long term, looking at events like heart attacks or the need for repeat procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: drug-eluting balloon (paclitaxel-coated balloon)
What this could lead to: If successful, this could confirm that drug-eluting balloons are a safe and effective option for treating coronary artery disease, potentially reducing the need for stents.
What could go wrong: This is an observational study, not a controlled trial, so results may be influenced by other factors. The balloon uses paclitaxel, which carries risks like allergic reactions or blood flow issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANGIOPLASTY, BALLOON are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANGIOPLASTY, BALLOON CORONARY ARTERY DISEASE

Contacts and locations

Locations

Asan Medical Center
RECRUITING

Seoul, South Korea
Chonnam National University Hospital
RECRUITING

Gwangju, South Korea
Dong-A Medical Center
RECRUITING

Pusan, South Korea
Gangnam Severance Hospital
RECRUITING

Seoul, South Korea
Keimyung University Dongsan Medical Center
RECRUITING

Daegu, South Korea
Korea University Guro Hospital
NOT_YET_RECRUITING

Seoul, South Korea
Soon Chun Hyang University Hospital Bucheon
TERMINATED

Bucheon-si, South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
TERMINATED

Daejeon, South Korea
Ulsan University Hospital
RECRUITING

Ulsan, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.